Cancer induced cachexia is a multifactorial syndrome that results in unexplained weight loss in cancer patients. A major cause of morbidity and mortality, the syndrome is most prevalent in pancreatic cancer. Here we have identified changes in brain choline metabolites and plasma choline in human pancreatic cancer xenografts that induce cachexia (Pa04C) as well as noncachexia inducing pancreatic cancer xenografts (Panc1), compared to normal mice. These results highlight the systemic changes in choline metabolism that occur with cancer and with cancer induced cachexia that may lead to the development of early biomarkers as well to metabolic treatment strategies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords